I know people who have died of this rare disease. It is a terrible disease, and yet not once did anyone ever mention at that hearing the possibility of accelerated approval.
Joe Pitts
The Public Record
Joseph R. Pitts is a former Republican member of the U.S. House of Representatives, serving Pennsylvania's 16th congressional district from 1997 to 2017. During his tenure, Pitts was known for his focus on healthcare, energy, and family issues, often advocating for conservative policies. He played a significant role in various legislative efforts, including those related to the Affordable Care Act and energy independence. Pitts was also involved with the Pennsylvania Family Institute, reflecting his commitment to family values and social issues.
I urge the committee to address this crisis head-on, and encourage meaningful development in the antibiotic space.
Congress does not have all the answers, but we do have a role to play in ensuring our Nation's laws and regulations keep pace and complement the biomedical research and innovation that is happening at lightning speed.
Through this effort, Congress hopes to clear a path to find more cures and treatments while also creating jobs and keeping America as the innovation center of the world.
Today's hearing relates to the 21st Century Cures Initiative announced by the Energy and Commerce Committee on April 30, 2014.
With Russian-backed militants creating chaos in Ukraine, neighboring Moldova has put their forces on high alert. Moldova and Ukraine share a similar problem of breakaway states within their borders. In fact, there is evidence that Russian…
The bottom line is that until we can attract more physicians to underserved communities and tighten the access gap, the best and most cost-efficient alternative is to improve telehealth networks.
One year ago today, April 30, 2014, the Energy and Commerce Committee embarked on an ambitious, bipartisan goal to develop legislation that would bring the medical innovation cycle of discovery, development, and delivery into the 21st…
The 2009 Tobacco Control Act was historic in saving legislation representing the first time the FDA was granted the authority to regulate tobacco products.
As the oversight body, I believe we should be able to see how these funds are being used, the number of applications being reviewed or still pending, and get a clear picture of the division's work.





